US4152170A
(en)
*
|
1975-06-18 |
1979-05-01 |
Sumitomo Chemical Company, Ltd. |
Cross-linked pullulan
|
US4344930A
(en)
*
|
1975-10-30 |
1982-08-17 |
Colgate-Palmolive Company |
Skin care sponge
|
US4470975A
(en)
*
|
1977-10-21 |
1984-09-11 |
The Johns Hopkins University |
Method and composition for the elimination of water from an animal body
|
SE445013B
(sv)
*
|
1979-06-21 |
1986-05-26 |
Landstingens Inkopscentral |
Medel for att forebygga eller behandla infektioner hos menniskor och djur
|
US4292972A
(en)
*
|
1980-07-09 |
1981-10-06 |
E. R. Squibb & Sons, Inc. |
Lyophilized hydrocolloio foam
|
DE3360633D1
(en)
*
|
1982-02-12 |
1985-10-03 |
Unitika Ltd |
Anti-cancer device
|
US4764380A
(en)
*
|
1982-03-22 |
1988-08-16 |
Alza Corporation |
Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
|
US4783448A
(en)
*
|
1983-06-07 |
1988-11-08 |
Perstorp Ab |
Method for cleansing an infected sore
|
SE456346B
(sv)
*
|
1984-07-23 |
1988-09-26 |
Pharmacia Ab |
Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
|
US4769022A
(en)
*
|
1986-05-02 |
1988-09-06 |
Minnesota Mining And Manufacturing Company |
Cleansing pad
|
SE452469B
(sv)
*
|
1986-06-18 |
1987-11-30 |
Pharmacia Ab |
Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
|
US4851232A
(en)
*
|
1987-02-13 |
1989-07-25 |
Alza Corporation |
Drug delivery system with means for obtaining desirable in vivo release rate pattern
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US5938654A
(en)
*
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US5019397A
(en)
*
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US5160743A
(en)
*
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5354290A
(en)
*
|
1989-05-31 |
1994-10-11 |
Kimberly-Clark Corporation |
Porous structure of an absorbent polymer
|
CA2017570C
(en)
*
|
1989-05-31 |
2000-12-19 |
James R. Gross |
Porous structure of an absorbent polymer
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5241009A
(en)
*
|
1990-05-07 |
1993-08-31 |
Kimberly-Clark Corporation |
Polymeric composition containing carboxy nueutralized with lithium or potassium
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
WO1993004732A1
(en)
|
1991-09-09 |
1993-03-18 |
The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Methods and devices for treating hemophilia and aids
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
US5525710A
(en)
*
|
1991-12-20 |
1996-06-11 |
Alliedsignal Inc. |
Highly porous chitosan bodies
|
DE69226203T2
(de)
*
|
1991-12-20 |
1998-12-10 |
Allied Signal Inc |
Materialien mit niedriger dichte und hoher spezifischer oberflaeche und daraus geformte artikel zur verwendung in der metallrueckgewinnung
|
US5502082A
(en)
*
|
1991-12-20 |
1996-03-26 |
Alliedsignal Inc. |
Low density materials having good compression strength and articles formed therefrom
|
US5223265A
(en)
*
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
DE4209160A1
(de)
*
|
1992-03-20 |
1993-09-30 |
Bauer Kurt Heinz Prof Dr |
Vernetzte Polysaccharide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
US6287598B1
(en)
*
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US5409703A
(en)
*
|
1993-06-24 |
1995-04-25 |
Carrington Laboratories, Inc. |
Dried hydrogel from hydrophilic-hygroscopic polymer
|
US5498255A
(en)
*
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
US5840338A
(en)
*
|
1994-07-18 |
1998-11-24 |
Roos; Eric J. |
Loading of biologically active solutes into polymer gels
|
DE4442605A1
(de)
*
|
1994-11-30 |
1996-06-05 |
Degussa |
Quellbarer Stärkeester, Verfahren zu dessen Herstellung sowie Verwendung
|
DE4442606C2
(de)
*
|
1994-11-30 |
1998-09-17 |
Degussa |
Quellbarer Stärkeester, Verfahren zu dessen Herstellung sowie Verwendung
|
US5817335A
(en)
*
|
1995-05-26 |
1998-10-06 |
Alza Corporation |
Osmotic device with high drug loading and delayed activation of drug delivery
|
US5800422A
(en)
*
|
1995-06-02 |
1998-09-01 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery and complete drug release
|
US5731001A
(en)
*
|
1995-06-07 |
1998-03-24 |
Magruder; Judy A. |
Locking couplings for osmotic delivery devices
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5902605A
(en)
*
|
1996-04-18 |
1999-05-11 |
Alza Corporation |
Drug delivery device with minimal residual drug retention
|
DE19729273C2
(de)
*
|
1997-07-09 |
2000-08-17 |
Aventis Res & Tech Gmbh & Co |
Thermoplastische Mischung auf 1,4-alpha-D-Polyglucanbasis, Verfahren zu deren Herstellung und Verwendung
|
CN1623533A
(zh)
|
1997-09-25 |
2005-06-08 |
拜尔公司 |
控释活性化合物的药物制剂
|
US6261679B1
(en)
|
1998-05-22 |
2001-07-17 |
Kimberly-Clark Worldwide, Inc. |
Fibrous absorbent material and methods of making the same
|
US7790192B2
(en)
|
1998-08-14 |
2010-09-07 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US6179862B1
(en)
|
1998-08-14 |
2001-01-30 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
US6632457B1
(en)
*
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
US6152943A
(en)
*
|
1998-08-14 |
2000-11-28 |
Incept Llc |
Methods and apparatus for intraluminal deposition of hydrogels
|
US6605294B2
(en)
*
|
1998-08-14 |
2003-08-12 |
Incept Llc |
Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
|
AU5560899A
(en)
*
|
1998-08-14 |
2000-03-06 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
US6703047B2
(en)
*
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
EP1147148B1
(de)
*
|
1998-08-31 |
2005-06-08 |
Cornell Research Foundation, Inc. |
Dextran-maleinsäuremonoester und hydrogele daraus
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
RU2246295C2
(ru)
*
|
1998-11-02 |
2005-02-20 |
Элзэ Копэрейшн |
Лекарственная форма c постоянной скоростью высвобождения лекарственного вещества, ядро лекарственной формы и способ обеспечения облегченного высвобождения лекарственного вещества из лекарственной формы
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
US6060461A
(en)
*
|
1999-02-08 |
2000-05-09 |
Drake; James Franklin |
Topically applied clotting material
|
EP1168934B1
(de)
|
1999-04-12 |
2008-02-13 |
Cornell Research Foundation, Inc. |
Hydrogel-formendes system mit hydrophoben und hydrophilen komponenten
|
US6716445B2
(en)
*
|
1999-04-12 |
2004-04-06 |
Cornell Research Foundation, Inc. |
Hydrogel entrapping therapeutic agent and stent with coating comprising this
|
US6541678B2
(en)
*
|
1999-09-27 |
2003-04-01 |
Brennen Medical, Inc. |
Immunostimulating coating for surgical devices
|
US20020071863A1
(en)
*
|
1999-12-09 |
2002-06-13 |
Dong Liang C. |
Antiviral medication
|
CA2431205C
(en)
|
2000-12-05 |
2005-08-23 |
Alexander Macgregor |
Hydrostatic delivery system for controlled delivery of agent
|
US20040219186A1
(en)
*
|
2001-08-16 |
2004-11-04 |
Ayres James W. |
Expandable gastric retention device
|
AU2002357935A1
(en)
*
|
2001-12-18 |
2003-06-30 |
Alza Corporation |
Dosage form for providing time-varying patterns of drug delivery
|
JP2005513095A
(ja)
*
|
2001-12-19 |
2005-05-12 |
アルザ・コーポレーシヨン |
治療剤の制御送達のための調合物&投薬形態物
|
IL162293A0
(en)
*
|
2001-12-19 |
2005-11-20 |
Alza Corp |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
NZ536252A
(en)
*
|
2002-04-29 |
2007-06-29 |
Alza Corp |
Methods and dosage forms for controlled delivery of oxycodone
|
AU2003245345A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Alza Corporation |
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
WO2004010970A1
(en)
*
|
2002-07-29 |
2004-02-05 |
Alza Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
GB2395126A
(en)
|
2002-11-09 |
2004-05-19 |
Reckitt Benckiser |
Volatile substance dispenser
|
AU2003298777B2
(en)
|
2002-11-26 |
2009-10-01 |
Danisco Us Inc. |
Optical information carrier comprising immobilized proteorhodopsin
|
US8709038B2
(en)
*
|
2002-12-20 |
2014-04-29 |
Boston Scientific Scimed, Inc. |
Puncture hole sealing device
|
US20040122349A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Lafontaine Daniel M. |
Closure device with textured surface
|
WO2004064772A2
(en)
*
|
2003-01-14 |
2004-08-05 |
Alza Corporation |
Methods and dosage forms with modified viscosity layers
|
US7331979B2
(en)
*
|
2003-06-04 |
2008-02-19 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US9289195B2
(en)
|
2003-06-04 |
2016-03-22 |
Access Closure, Inc. |
Auto-retraction apparatus and methods for sealing a vascular puncture
|
EP2529730A1
(de)
|
2003-06-16 |
2012-12-05 |
ANDRX Pharmaceuticals LLC. |
Orale Zusammensetzung mit verlängerter Freisetzung
|
US7942897B2
(en)
*
|
2003-07-10 |
2011-05-17 |
Boston Scientific Scimed, Inc. |
System for closing an opening in a body cavity
|
DE10336400A1
(de)
*
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
PT1842533E
(pt)
*
|
2003-08-06 |
2013-05-17 |
Gruenenthal Gmbh |
Forma de dosagem protegida contra abuso
|
DE102005005446A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
US20070048228A1
(en)
*
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102004032051A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
WO2005016306A2
(en)
*
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
US7927626B2
(en)
*
|
2003-08-07 |
2011-04-19 |
Ethicon, Inc. |
Process of making flowable hemostatic compositions and devices containing such compositions
|
EP1658048A2
(de)
*
|
2003-08-22 |
2006-05-24 |
ALZA Corporation |
Schrittweise abgabe von topiramat über einen längeren zeitraum
|
WO2005020959A2
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
JP5563731B2
(ja)
*
|
2003-09-26 |
2014-07-30 |
アルザ・コーポレーシヨン |
オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
|
NZ546148A
(en)
|
2003-09-26 |
2009-05-31 |
Alza Corp |
Drug coating providing high drug loading and methods for providing the same
|
MXPA06003453A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Barra de empuje oros para el suministro controlado de agentes activos.
|
WO2005048981A1
(en)
*
|
2003-11-14 |
2005-06-02 |
Alza Corporation |
Controlled release of topirimate in liquid dosage forms
|
US20050107867A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Taheri Syde A. |
Temporary absorbable venous occlusive stent and superficial vein treatment method
|
WO2005063206A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
WO2005065648A2
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc., |
Novel drug compositions and dosage forms of topiramate
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
EP1701706A2
(de)
*
|
2003-12-29 |
2006-09-20 |
Alza Corporation |
Neue arzneimittelzusammensetzungen und dosierformen
|
US20050234336A1
(en)
*
|
2004-03-26 |
2005-10-20 |
Beckman Andrew T |
Apparatus and method for marking tissue
|
DE102004023069A1
(de)
|
2004-05-11 |
2005-12-08 |
Bayer Healthcare Ag |
Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
|
US20050276848A1
(en)
*
|
2004-06-15 |
2005-12-15 |
Nilobon Podhipleux |
Sustained release neutralized divalproex sodium
|
US7713550B2
(en)
*
|
2004-06-15 |
2010-05-11 |
Andrx Corporation |
Controlled release sodium valproate formulation
|
US20050287185A1
(en)
*
|
2004-06-23 |
2005-12-29 |
David Wong |
Extended release oxybutynin formulation
|
EP1761265A2
(de)
*
|
2004-06-28 |
2007-03-14 |
ALZA Corporation |
Arzneimittel/polymer-komplex, vorzugsweise ciprofloxacin/hpmc, sein herstellungsverfahren mit lyophilisation und seine verwendung in einer osmotischen vorrichtung
|
US20050287213A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Wong Patrick S |
Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
|
US8709469B2
(en)
|
2004-06-30 |
2014-04-29 |
Abbott Cardiovascular Systems Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
US8080705B2
(en)
*
|
2004-07-28 |
2011-12-20 |
The Procter & Gamble Company |
Superabsorbent polymers comprising direct covalent bonds between polymer chain segments and method of making them
|
WO2006023286A2
(en)
*
|
2004-08-19 |
2006-03-02 |
Alza Corporation |
Controlled release nanoparticle active agent formulation dosage forms and methods
|
US8348971B2
(en)
|
2004-08-27 |
2013-01-08 |
Accessclosure, Inc. |
Apparatus and methods for facilitating hemostasis within a vascular puncture
|
US20060052822A1
(en)
*
|
2004-08-31 |
2006-03-09 |
Mirizzi Michael S |
Apparatus and material composition for permanent occlusion of a hollow anatomical structure
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
US8262693B2
(en)
*
|
2004-11-05 |
2012-09-11 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US7972354B2
(en)
*
|
2005-01-25 |
2011-07-05 |
Tyco Healthcare Group Lp |
Method and apparatus for impeding migration of an implanted occlusive structure
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
US7611494B2
(en)
|
2005-02-08 |
2009-11-03 |
Confluent Surgical, Inc. |
Spray for fluent materials
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
JP2008536928A
(ja)
*
|
2005-04-19 |
2008-09-11 |
アルザ・コーポレーシヨン |
トラマドール及び、ガバペンチンを含んでなる物質、の組み合わせ物
|
US7806856B2
(en)
*
|
2005-04-22 |
2010-10-05 |
Accessclosure, Inc. |
Apparatus and method for temporary hemostasis
|
JP5095615B2
(ja)
|
2005-06-27 |
2012-12-12 |
バリアント・インターナショナル・(バルバドス)・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ |
ブプロピオン塩の放出調整製剤
|
WO2007002872A2
(en)
*
|
2005-06-29 |
2007-01-04 |
Alza Corporation |
Semi-permeable compositions providing reduced drying time for osmotic dosage forms
|
US20070031496A1
(en)
*
|
2005-08-04 |
2007-02-08 |
Edgren David E |
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
|
US20070087061A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Medafor, Incorporated |
Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090041825A1
(en)
|
2006-02-10 |
2009-02-12 |
Kotov Nicholas A |
Cell culture well-plates having inverted colloidal crystal scaffolds
|
US8795709B2
(en)
*
|
2006-03-29 |
2014-08-05 |
Incept Llc |
Superabsorbent, freeze dried hydrogels for medical applications
|
US9017361B2
(en)
*
|
2006-04-20 |
2015-04-28 |
Covidien Lp |
Occlusive implant and methods for hollow anatomical structure
|
WO2008033964A2
(en)
|
2006-09-13 |
2008-03-20 |
Accessclosure, Inc. |
Apparatus for sealing a vascular puncture
|
US8623842B2
(en)
*
|
2006-09-27 |
2014-01-07 |
Hemostasis, Llc |
Hemostatic agent and method
|
US8414550B2
(en)
|
2006-09-29 |
2013-04-09 |
Lexion Medical, Llc |
System and method to vent gas from a body cavity
|
JPWO2008084698A1
(ja)
|
2006-12-28 |
2010-04-30 |
アステラス製薬株式会社 |
タクロリムス徐放性医薬組成物
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
DE102007011485A1
(de)
*
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
US20090062233A1
(en)
*
|
2007-08-09 |
2009-03-05 |
Xin Ji |
Modified starch material of biocompatible hemostasis
|
US7993367B2
(en)
*
|
2007-09-28 |
2011-08-09 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US20090088723A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Accessclosure, Inc. |
Apparatus and methods for treating pseudoaneurysms
|
US20090087484A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
WO2009059217A2
(en)
*
|
2007-11-02 |
2009-05-07 |
Incept, Llc |
Apparatus and methods for sealing a vascular puncture
|
CN104888263B
(zh)
*
|
2008-01-14 |
2018-11-30 |
北京环球利康科技有限公司 |
生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料
|
AU2009207796B2
(en)
|
2008-01-25 |
2014-03-27 |
Grunenthal Gmbh |
Pharmaceutical dosage form
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
JP5569398B2
(ja)
|
2008-02-29 |
2014-08-13 |
フェッローサン メディカル ディバイス エー/エス |
止血および/または創傷治癒を促進するための装置
|
US8585646B2
(en)
|
2008-03-03 |
2013-11-19 |
Lexion Medical, Llc |
System and method to vent gas from a body cavity
|
US9061087B2
(en)
*
|
2008-03-04 |
2015-06-23 |
Hemostasis, Llc |
Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
|
US8029533B2
(en)
|
2008-04-04 |
2011-10-04 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US9364206B2
(en)
|
2008-04-04 |
2016-06-14 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
ES2599031T3
(es)
*
|
2008-05-09 |
2017-01-31 |
Grünenthal GmbH |
Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización
|
US10799593B2
(en)
|
2008-06-09 |
2020-10-13 |
Northwestern University |
Nanodiamond particle complexes
|
US20100040672A1
(en)
*
|
2008-06-09 |
2010-02-18 |
Northwestern University |
Delivery of therapeutics
|
EP2364112B1
(de)
*
|
2008-11-12 |
2016-03-09 |
Accessclosure, Inc. |
Gerät und verfahren zur abdichtung einer gefässpunktion
|
EP2396070A4
(de)
*
|
2009-02-12 |
2012-09-19 |
Incept Llc |
Wirkstofffreisetzung mit hydrogel-plugs
|
CA2760704C
(en)
*
|
2009-05-04 |
2017-10-03 |
Incept, Llc |
Biomaterials for track and puncture closure
|
EP2548950B1
(de)
|
2009-06-05 |
2017-10-25 |
Cellular Dynamics International, Inc. |
Umprogrammierung von T-Zellen und hämatopoetischen Zellen
|
PT2456424E
(pt)
|
2009-07-22 |
2013-09-30 |
Gruenenthal Gmbh |
Forma de dosagem resistente à adulteração e estabilizada contra a oxidação
|
NZ596667A
(en)
|
2009-07-22 |
2013-09-27 |
Gruenenthal Chemie |
Hot-melt extruded controlled release dosage form
|
US20110052663A1
(en)
*
|
2009-09-01 |
2011-03-03 |
Hemostasis, Llc |
Hemostatic Sponge with Enzyme and Method of Manufacture
|
US8434489B2
(en)
|
2009-10-23 |
2013-05-07 |
Conceptus, Inc. |
Contraceptive devices and methods
|
JP5820815B2
(ja)
|
2009-12-15 |
2015-11-24 |
インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc |
インプラントおよび生体分解性基準マーカー
|
WO2011095314A2
(en)
*
|
2010-02-03 |
2011-08-11 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
DE102010012183A1
(de)
*
|
2010-03-19 |
2011-09-22 |
Fresenius Medical Care Deutschland Gmbh |
Veresterte Polysaccharid-Osmotika
|
PL2554168T3
(pl)
|
2010-03-29 |
2018-05-30 |
Astellas Pharma Inc. |
Kompozycja farmaceutyczna do kontrolowanego uwalniania
|
MX2013002377A
(es)
|
2010-09-02 |
2013-04-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
|
CA2808541C
(en)
|
2010-09-02 |
2019-01-08 |
Gruenenthal Gmbh |
Tamper resistant dosage form comprising an anionic polymer
|
US9820728B2
(en)
|
2011-01-19 |
2017-11-21 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
WO2012100091A2
(en)
|
2011-01-19 |
2012-07-26 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US9386968B2
(en)
|
2011-05-11 |
2016-07-12 |
Access Closure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
MX348054B
(es)
|
2011-07-29 |
2017-05-25 |
Gruenenthal Gmbh |
Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco.
|
AR087360A1
(es)
|
2011-07-29 |
2014-03-19 |
Gruenenthal Gmbh |
Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
|
US9205150B2
(en)
|
2011-12-05 |
2015-12-08 |
Incept, Llc |
Medical organogel processes and compositions
|
JP2012107033A
(ja)
*
|
2012-02-02 |
2012-06-07 |
Medafor Inc |
局所適用される凝血材料
|
AU2013225106B2
(en)
|
2012-02-28 |
2017-11-02 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
EP2822474B1
(de)
|
2012-03-06 |
2018-05-02 |
Ferrosan Medical Devices A/S |
Druckbehälter mit einer blutstillenden paste
|
US9757105B2
(en)
|
2012-03-23 |
2017-09-12 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
US8721680B2
(en)
|
2012-03-23 |
2014-05-13 |
Accessclosure, Inc. |
Apparatus and methods for sealing a vascular puncture
|
RS57913B1
(sr)
|
2012-04-18 |
2019-01-31 |
Gruenenthal Gmbh |
Farmaceutske dozne forme otporne na neovlašćenu upotrebu i naglo oslobađanje celokupne doze
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
AU2013275758B2
(en)
|
2012-06-12 |
2015-03-12 |
Ferrosan Medical Devices A/S |
Dry haemostatic composition
|
JP6466417B2
(ja)
|
2013-05-29 |
2019-02-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形
|
JP6445537B2
(ja)
|
2013-05-29 |
2018-12-26 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
1個または複数の粒子を含有する改変防止(tamper−resistant)剤形
|
AU2014283170B2
(en)
|
2013-06-21 |
2017-11-02 |
Ferrosan Medical Devices A/S |
Vacuum expanded dry composition and syringe for retaining same
|
US10765774B2
(en)
|
2013-07-09 |
2020-09-08 |
Ethicon, Inc. |
Hemostatic pad assembly kit and method
|
JP6449871B2
(ja)
|
2013-07-12 |
2019-01-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
エチレン−酢酸ビニルポリマーを含有する改変防止剤形
|
BR112016010482B1
(pt)
|
2013-11-26 |
2022-11-16 |
Grünenthal GmbH |
Preparação de uma composição farmacêutica em pó por meio de criomoagem
|
JP6489485B2
(ja)
|
2013-12-11 |
2019-03-27 |
フェロサン メディカル デバイシーズ エイ/エス |
押し出し増強因子を含んでいる乾燥組成物
|
WO2015173195A1
(en)
|
2014-05-12 |
2015-11-19 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
JP2017516789A
(ja)
|
2014-05-26 |
2017-06-22 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
エタノール過量放出に対して防護されている多粒子
|
BR112017007466B1
(pt)
|
2014-10-13 |
2021-03-02 |
Ferrosan Medical Devices A/S |
método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
|
US10550187B2
(en)
|
2014-10-24 |
2020-02-04 |
Incept, Llc |
Extra luminal scaffold
|
EP3229779B1
(de)
|
2014-12-10 |
2021-02-03 |
Incept, LLC |
Hydrogel-wirkstofffreisetzungsimplantate
|
US10653837B2
(en)
|
2014-12-24 |
2020-05-19 |
Ferrosan Medical Devices A/S |
Syringe for retaining and mixing first and second substances
|
EA035434B1
(ru)
|
2015-04-24 |
2020-06-15 |
Грюненталь Гмбх |
Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями
|
JP2018515529A
(ja)
|
2015-05-12 |
2018-06-14 |
インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc |
ハイドロゲルからの薬物送達
|
US10918796B2
(en)
|
2015-07-03 |
2021-02-16 |
Ferrosan Medical Devices A/S |
Syringe for mixing two components and for retaining a vacuum in a storage condition
|
US10842750B2
(en)
|
2015-09-10 |
2020-11-24 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
AU2016361579B2
(en)
|
2015-11-25 |
2022-08-04 |
Incept, Llc |
Shape changing drug delivery devices and methods
|
KR20230053707A
(ko)
|
2016-09-23 |
2023-04-21 |
인셉트, 엘엘씨 |
전안방내 약물 전달 데포
|
MX2020008527A
(es)
|
2018-02-16 |
2020-09-18 |
Esperion Therapeutics Inc |
Formulaciones de liberacion sostenida de acido bempedoico.
|
AU2019266529A1
(en)
|
2018-05-09 |
2020-12-03 |
Ethicon Inc. |
Method for preparing a haemostatic composition
|
CN110732037B
(zh)
|
2018-07-20 |
2023-05-26 |
广州倍绣生物技术有限公司 |
止血糊剂及其制备方法
|
JPWO2021029020A1
(de)
|
2019-08-13 |
2021-02-18 |
|
|
US11739166B2
(en)
|
2020-07-02 |
2023-08-29 |
Davol Inc. |
Reactive polysaccharide-based hemostatic agent
|
CN113304305A
(zh)
*
|
2021-04-27 |
2021-08-27 |
宁波绿糖生物科技有限公司 |
一种葡聚糖微球及其制备方法和应用
|